Breast Cancer

Showing NaN - NaN of 143

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Organoid Model Predictive of Response to Immunotherapies

Recruiting
  • Breast Cancer
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Oct 10, 2023

Breast Cancer Trial in Worldwide (palliative surgery, therapeutic conventional surgery, palliative radiation therapy)

Completed
  • Breast Cancer
  • Stage IV Breast Cancer
  • palliative surgery
  • +3 more
  • Mobile, Alabama
  • +376 more
Jan 6, 2023

Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)

Active, not recruiting
  • Breast Cancer
  • Positron emission tomography (PET)
  • +2 more
  • Birmingham, Alabama
  • +9 more
Jan 20, 2023

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

Recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +5 more
Jan 12, 2023

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

Breast Cancer Trial in Worldwide (Olaparib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Anchorage, Alabama
  • +698 more
Nov 25, 2022

Breast Cancer, Cognitive Change, Cognitive Impairment Trial in Indianapolis (Sweep Seeker, Bird Safari, Jewel Diver)

Completed
  • Breast Cancer
  • +3 more
  • Sweep Seeker
  • +5 more
  • Indianapolis, Indiana
    Indiana University School of Nursing
Oct 4, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Malignant Tumor of Breast, Breast Cancer Trial in United States (Genomically Directed Monotherapy, Observation/Standard Therapy)

Active, not recruiting
  • Malignant Neoplasm of Breast
  • Breast Cancer
  • Genomically Directed Monotherapy
  • Observation/Standard Therapy
  • Birmingham, Alabama
  • +28 more
Aug 30, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
  • Breast Cancer
  • Chandler, Arizona
  • +166 more
Jul 21, 2022

Breast Tumor, Breast Cancer, Breast Carcinoma Trial in Indianapolis (Enhanced Usual Care, Acceptance Commitment Therapy,

Recruiting
  • Breast Neoplasm
  • +11 more
  • Enhanced Usual Care
  • +2 more
  • Indianapolis, Indiana
    Indiana University-Purdue University Indianapolis
Jul 23, 2022

Breast Cancer, Indolent Metastatic Breast Cancer Trial in Avon, Carmel, Indianapolis (Exercise Intervention)

Not yet recruiting
  • Breast Cancer
  • Indolent Metastatic Breast Cancer
  • Exercise Intervention
  • Avon, Indiana
  • +3 more
Jul 18, 2022

Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)

Active, not recruiting
  • Breast Cancer
  • therapeutic conventional surgery
  • whole breast irradiation
  • Hot Springs, Arkansas
  • +349 more
Jun 16, 2022

Breast Cancer Trial in Indianapolis (SNDX-275)

Terminated
  • Breast Cancer
  • Indianapolis, Indiana
    Monet Bowling, MD
Jun 1, 2022

Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +7 more
May 15, 2022

Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +132 more
Apr 26, 2022

Breast Cancer Trial in Ireland, United States (bevacizumab, docetaxel, doxorubicin)

Completed
  • Breast Cancer
  • Bessemer, Alabama
  • +532 more
Apr 13, 2022

Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +437 more
Mar 21, 2022

Breast Cancer Trial in United States (Trastuzumab, Paclitaxel, Trastuzumab emtansine)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +84 more
Mar 15, 2022

Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

Terminated
  • Triple-Negative Breast Neoplasms
  • +3 more
  • Tucson, Arizona
  • +53 more
Feb 24, 2022

Breast Cancer Trial in United States (Palbociclib, Aromatase Inhibitor)

Completed
  • Breast Cancer
  • San Francisco, California
  • +9 more
Mar 18, 2022

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022